Five-Year Outcome of 215 Newly Diagnosed Chronic Myeloid Leukemia Patients Treated Frontline with Nilotinib-Based Regimens: A Gimema CML Working Party Analysis

被引：0

作者：

Gugliotta, Gabriele ^{[1
]}

Castagnetti, Fausto ^{[1
]}

Breccia, Massimo ^{[2
]}

Levato, Luciano ^{[3
]}

Rege-Cambrin, Giovanna ^{[4
]}

Luciano, Luigiana ^{[5
]}

Bocchia, Monica ^{[6
]}

Rossi, Antonella Russo ^{[7
]}

Usala, Emilio ^{[8
]}

Salvucci, Marzia ^{[9
]}

Gozzini, Antonella ^{[10
]}

Binotto, Gianni ^{[11
]}

Cedrone, Michele ^{[12
]}

Abruzzese, Elisabetta ^{[13
]}

Avanzini, Paolo ^{[14
]}

Venturi, Claudia ^{[1
]}

Testoni, Nicoletta ^{[1
]}

Soverini, Simona ^{[1
]}

Alimena, Giuliana ^{[2
]}

Cavo, Michele ^{[1
]}

Martinelli, Giovanni ^{[1
]}

Pane, Fabrizio ^{[15
]}

Saglio, Giuseppe ^{[16
]}

Baccarani, Michele ^{[17
]}

Rosti, Gianantonio ^{[1
]}

机构：

[1] Univ Bologna, Sch Med, Bologna, Italy

[2] Univ Roma La Sapienza, I-00185 Rome, Italy

[3] Azienda Osped Pugliese Ciaccio, Catanzaro, Italy

[4] Univ Turin, San Luigi Gonzaga Hosp, Orbassano, Italy

[5] Univ Naples Federico II, Naples, Italy

[6] Univ Siena, I-53100 Siena, Italy

[7] Univ Bari, Bari, Italy

[8] Osped Oncol A Businco, UO Ematol & CTMO, Cagliari, Italy

[9] Osped Santa Maria delle Croci, Ravenna, Italy

[10] AOU Careggi, Florence, Italy

[11] Univ Padua, Padua, Italy

[12] Azienda Osped S Giovanni Addolorata, Rome, Italy

[13] Osped S Eugenio, Rome, Italy

[14] Azienda Osped S Maria Nuova, Reggio Emilia, Italy

[15] Univ Naples Federico II, Naples, Italy

[16] Univ Turin, Osped San Luigi Gonzaga, Dept Clin & Biol Sci, Orbassano, Italy

[17] Univ Bologna, Bologna, Italy

来源：

BLOOD | 2014年 / 124卷 / 21期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 50 条

[41] Comparison of the Outcome between Newly Diagnosed Patients in the Accelerated Phase and Chronic Phase with Chronic Myeloid Leukemia Treated with Frontline Tyrosine Kinase Inhibitors
Jiang, Qian
Yu, Lu
Qin, Ya-Zhen
Lai, Yue-Yun
Huang, Xiao-Jun
BLOOD, 2017, 130
[42] LONG TERM OUTCOME OF 559 PH+ CHRONIC MYELOID LEUKEMIA PATIENTS TREATED FRONT-LINE WITH IMATINIB: 5-YEAR RESULTS OF 3 INDEPENDENT STUDIES OF THE GIMEMA CML WORKING PARTY
Castagnetti, F.
Palandri, F.
Gugliotta, G.
Breccia, M.
Specchia, G.
Abruzzese, E.
Levato, L.
Intermesoli, T.
Martino, B.
Pregno, P.
Orlandi, E.
Iacobucci, I.
Soverini, S.
Testoni, N.
Alimena, G.
Martinelli, G.
Pane, F.
Saglio, G.
Baccarani, M.
Rosti, G.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 54 - 54
[43] Comparison of nilotinib and imatinib in patients (pts) with newly diagnosed chronic myeloid leukemia in ehronic phase (CML-CP): ENESTnd beyond one year
Larson, R. A.
le Coutre, P. D.
Reiffers, J.
Hughes, T. P.
Saglio, G.
Edrich, P.
Hoenekopp, A.
Gallagher, N. J.
Kantarjian, H.
Hochhaus, A.
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[44] Rates of deep molecular response by digital and conventional PCR with frontline nilotinib in newly diagnosed chronic myeloid leukemia: a landmark analysis
Berdeja, Jesus G.
Heinrich, Michael C.
Dakhil, Shaker R.
Goldberg, Stuart L.
Wadleigh, Martha
Kuriakose, Philip
Cortes, Jorge
Radich, Jerald
Helton, Bret
Rizzieri, David
Paley, Carole
Dautaj, Ilva
Mauro, Michael J.
LEUKEMIA & LYMPHOMA, 2019, 60 (10) : 2384 - 2393
[45] Gimema Registry of Conception/Pregnancy in Adult Patients Diagnosed with Chronic Myeloid Leukemia (CML) Treated with Tyrosine Kinase Inhibitors (TKIs)
Abruzzese, Elisabetta
Scortechini, Anna Rita
Gugliotta, Gabriele
Pierri, Ivana
Musolino, Caterina
Iurlo, Alessandra
Mastrullo, Lucia
Caracciolo, Clementina
Orlandi, Ester
Galimberti, Sara
Salvucci, Marzia
Avanzini, Paolo
Sica, Simona
Alimena, Giuliana
Bocchia, Monica
Pregno, Patrizia
D'Emilio, Anna
Gambacorti-Passerini, Carlo
Stagno, Fabio
Santorsola, Domenico
Castagnetti, Fausto
Perrotti, Alessio Pio
de Fabritiis, Paolo
Baccarani, Michele
BLOOD, 2014, 124 (21)
[46] Ten-Year Follow-up of Patients with Chronic Myeloid Leukemia Treated with Nilotinib in First-Line: Final Results of the Gimema CML 0307 Trial
Gugliotta, Gabriele
Castagnetti, Fausto
Breccia, Massimo
Levato, Luciano
Intermesoli, Tamara
D'adda, Mariella
Salvucci, Marzia
Stagno, Fabio
Cambrin, Giovanna Rege
Tiribelli, Mario
Martino, Bruno
Bocchia, Monica
Trabacchi, Elena
Cavazzini, Francesco
Porretto, Ferdinando
Sora, Federica
Caocci, Giovanni
Albano, Francesco
Martinelli, Giovanni
Soverini, Simona
Foa, Robin
Pane, Fabrizio
Cavo, Michele
Saglio, Giuseppe
Baccarani, Michele
Rosti, Gianantonio
BLOOD, 2019, 134
[47] Correction to: Long-term outcomes with frontline nilotinib versus imatinib in newly diagnosed chronic myeloid leukemia in chronic phase: ENESTnd 10-year analysis
Hagop M. Kantarjian
Timothy P. Hughes
Richard A. Larson
Dong-Wook Kim
Surapol Issaragrisil
Philipp le Coutre
Gabriel Etienne
Carla Boquimpani
Ricardo Pasquini
Richard E. Clark
Viviane Dubruille
Ian W. Flinn
Slawomira Kyrcz-Krzemien
Ewa Medras
Maria Zanichelli
Israel Bendit
Silvia Cacciatore
Ksenia Titorenko
Paola Aimone
Giuseppe Saglio
Andreas Hochhaus
Leukemia, 2021, 35 : 2142 - 2143
[48] Chronic Myeloid Leukemia (CML) Patients with "Suboptimal" Response to Imatinib (IM) According to European LeukemiaNet Criteria Have a Poorer Outcome with Respect to "Optimal" Responders: A GIMEMA CML WORKING PARTY Analysis.
Castagnetti, Fausto
Gugliotta, Gabriele
Palandri, Francesca
Breccia, Massimo
Amabile, Marilina
Iacobucci, Ilaria
Testoni, Nicoletta
Marzocchi, Giulia
Luatti, Simona
Specchia, Giorgina
Intermesoli, Tamara
Abruzzese, Elisabetta
Capucci, Adele
Levato, Luciano
Radaelli, Franca
Martino, Bruno
Pregno, Patrizia
Montefusco, Enrico
Trentin, Livio
Alimena, Giuliana
Martinelli, Giovanni
Pane, Fabrizio
Saglio, Giuseppe
Baccarani, Michele
Rosti, Gianantonio
BLOOD, 2009, 114 (22) : 864 - 864
[49] Nilotinib versus imatinib in patients (pts) with newly diagnosed chronic myeloid leukemia in chronic phase (CML-CP): ENESTnd 4-year (y) update
Larson, Richard A.
Hochhaus, Andreas
Saglio, Giuseppe
Kim, Dong-Wook
Jootar, Saengsuree
Le Coutre, Philipp D.
Reiffers, Josy
Pasquini, Ricardo
Goldberg, Stuart L.
Clark, Richard E.
Kemp, Charisse N.
Fan, Xiaolin
Menssen, Hans D.
Hughes, Timothy P.
Kantarjian, Hagop M.
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
[50] Old Age Affects Survival but Not Response in Philadelphia Positive (Ph+) Chronic Myeloid Leukemia (CML) Patients Treated with Imatinib (IM): A Study of the GIMEMA CML WORKING PARTY.
Gugliotta, Gabriele
Castagnetti, Fausto
Palandri, Francesca
Breccia, Massimo
Amabile, Marilina
Soverini, Simona
Testoni, Nicoletta
Marzocchi, Giulia
Baldazzi, Carmen
Annunziata, Mario
Usala, Emilio
Sica, Simona
Tiribelli, Mario
Bocchia, Monica
Gozzini, Antonella
Russo, Sabina
Palmieri, Fausto
Meneghini, Vittorio
D'Emilio, Anna
Alimena, Giuliana
Martinelli, Giovanni
Pane, Fabrizio
Saglio, Giuseppe
Baccarani, Michele
Rosti, Gianantonio
BLOOD, 2009, 114 (22) : 458 - 459

← 1 2 3 4 5 →